Pharmacokinetics of Misoprostol With Titrated Oral Administration
NCT ID: NCT01271257
Last Updated: 2016-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
10 participants
INTERVENTIONAL
2011-01-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Misoprostol For Nulliparous Women Before Hysteroscopy
NCT01156948
Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy
NCT03638856
Titrated Oral Compared With Vaginal Misoprostol for Labor Induction at Term
NCT00529295
Comparative Bioavailability Study of Two Misoprostol Formulations
NCT02516631
Study of Effect of Vaginal ph and Acidification of Vaginal Misoprostol on Its Efficacy for Induction of Midtrimester Abortion
NCT01241045
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hourly misoprostol
20 microgram misoprostol intake per hour
Misoprostol
20 microgram PO per hour for 8 doses or 80 microgram PO per 4 hours for 2 doses
traditional misoprostol
80 microgram misoprostol intake per 4 hours
Misoprostol
20 microgram PO per hour for 8 doses or 80 microgram PO per 4 hours for 2 doses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Misoprostol
20 microgram PO per hour for 8 doses or 80 microgram PO per 4 hours for 2 doses
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China Medical University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shi-Yann Cheng
Director of Department of Obstetrics and Gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shi-Yann Cheng, M.D.
Role: PRINCIPAL_INVESTIGATOR
China Medical University Beigang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China Medical University Beigang Hospital
Yunlin Xian, Taiwan, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod. 2002 Feb;17(2):332-6. doi: 10.1093/humrep/17.2.332.
Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997 Jul;90(1):88-92. doi: 10.1016/S0029-7844(97)00111-7.
Related Links
Access external resources that provide additional context or updates about the study.
China Medical University Beigang Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DMR-IRB-242
Identifier Type: OTHER
Identifier Source: secondary_id
CMUBH R990011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.